Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Negat Results Biomed ; 15(1): 18, 2016 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-27784318

RESUMEN

BACKGROUND: Mutations in the human progressive ankylosis gene (ANKH; Mus musculus ortholog Ank) have been identified as cause for craniometaphyseal dysplasia (CMD), characterized by progressive thickening of craniofacial bones and flared metaphyses of long bones. We previously reported a knock-in (KI) mouse model (Ank KI/KI) for CMD and showed transiently lower serum phosphate (Pi) as well as significantly higher mRNA levels of fibroblast growth factor 23 (Fgf23) in Ank KI/KI mice. FGF23 is secreted by bone and acts in kidney to promote Pi wasting which leads to lower serum Pi levels. Here, we examined whether increasing the Pi level can partially rescue the CMD-like skeletal phenotype by feeding Ank +/+ and Ank KI/KI mice with high Pi (1.7 %) diet from birth for 6 weeks. We studied the Pi metabolism in Ank KI/KI mice and CMD patients by examining the Pi regulators FGF23 and parathyroid hormone (PTH). RESULTS: High Pi diet did not correct CMD-like features, including massive jawbone, increased endosteal and periosteal perimeters and extensive trabeculation of femurs in Ank KI/KI mice shown by computed microtomography (µCT). This unexpected negative result is, however, consistent with normal serum/plasma levels of the intact/active form of FGF23 and PTH in Ank KI/KI mice and in CMD patients. In addition, FGF23 protein expression was unexpectedly normal in Ank KI/KI femoral cortical bone as shown by immunohistochemistry despite increased mRNA levels for Fgf23. Renal expression of genes involved in the FGF23 bone-kidney axis, including mFgfr1, mKlotho, mNpt2a, mCyp24a1 and m1αOHase, were comparable between Ank +/+ and Ank KI/KI mice as shown by quantitative real-time PCR. Different from normal FGF23 and PTH, serum 25-hydroxyvitamin D was significantly lower in Ank KI/KI mice and vitamin D insufficiency was found in four out of seven CMD patients. CONCLUSIONS: Our data suggests that FGF23 signaling and Pi metabolism are not significantly affected in CMD and transiently low Pi level is not a major contributor to CMD.


Asunto(s)
Enfermedades del Desarrollo Óseo/tratamiento farmacológico , Huesos/patología , Anomalías Craneofaciales/tratamiento farmacológico , Dieta , Suplementos Dietéticos , Hiperostosis/tratamiento farmacológico , Hipertelorismo/tratamiento farmacológico , Fosfatos/uso terapéutico , Adolescente , Animales , Peso Corporal/efectos de los fármacos , Enfermedades del Desarrollo Óseo/sangre , Enfermedades del Desarrollo Óseo/genética , Huesos/diagnóstico por imagen , Huesos/efectos de los fármacos , Niño , Anomalías Craneofaciales/sangre , Anomalías Craneofaciales/genética , Modelos Animales de Enfermedad , Femenino , Factor-23 de Crecimiento de Fibroblastos , Factores de Crecimiento de Fibroblastos/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Hiperostosis/sangre , Hiperostosis/genética , Hipertelorismo/sangre , Hipertelorismo/genética , Riñón/efectos de los fármacos , Riñón/metabolismo , Masculino , Ratones Endogámicos C57BL , Persona de Mediana Edad , Tamaño de los Órganos/efectos de los fármacos , Hormona Paratiroidea/sangre , Fenotipo , Fosfatos/farmacología , Vitamina D/análogos & derivados , Vitamina D/sangre , Microtomografía por Rayos X
2.
Rev Invest Clin ; 65(1): 39-51, 2013.
Artículo en Español | MEDLINE | ID: mdl-23745443

RESUMEN

INTRODUCTION: Propranolol (P) treatment exerts a preventive effect against the detrimental consequences to bone status in mildly chronically food-restricted growing rats (NGR) by an increment in cortical bone and by improving its spatial distribution. OBJECTIVE: To study the effect of beta-blocker on operational mechanism of bone mechanostat in an animal model of nutritional stress. MATERIAL AND METHODS: Weanling male Wistar rats were randomly assigned to four groups: control (C), C + P (CP), NGR and NGR + P (NGRP). C and CP rats were fed freely with the standard diet. NGR and NGRP rats received, for 4 weeks, 80% of the amount of food consumed by C and CP respectively, the previous day, corrected by body weight. Propranolol (7 mg/kg/day) was injected ip 5 days per week, for four weeks in CP and NGRP rats. C and NGR received saline injections at an identical dosage regimen. Body weight and length were determined during the experimental period. Dietary intake was registered daily. Animals were sacrificed after 4 weeks of food restriction. Immediately, cuadriceps, femur and tibiae from each animal were dissected and weighed, and histomorphometric and mechanical studies were performed. Serum a-CTX, osteocalcin, intact PTH, calcium and phosphorous were determined. Body protein (% prot) was measured in all groups. RESULTS: Food restriction induced detrimental effects on body and femoral growth, load-bearing capacity (Wf), % prot and cuadriceps weight in NGR us. C (p < 0.01). beta-blocker did not modify anthropometric and bone morphometric parameters in NGRP and CP us. NGR and C, respectively (p > 0.05). However, Wf NGRP vs. NGR was significantly higher (p < 0.01). alpha-CTX was significantly higher in NGR vs. C (p < 0.01). No significant differences were observed in alpha-CTX levels between CP, NGRP and C (p > 0.05). Serum osteocalcin, intact PTH, calcium and phospho- rous showed no significant difference between groups (p > 0.05). CONCLUSION: These results suggest that modeling increase in bone mass and strength in NGRP rats could be due to an anticatabolic interaction of the beta-blocker propranolol on operational mechanism of bone mechanostat in an animal model of nutritional stress.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Enfermedades del Desarrollo Óseo/prevención & control , Privación de Alimentos/fisiología , Trastornos del Crecimiento/prevención & control , Desnutrición/fisiopatología , Propranolol/uso terapéutico , Antagonistas Adrenérgicos beta/farmacología , Animales , Biomarcadores , Peso Corporal/efectos de los fármacos , Enfermedades del Desarrollo Óseo/sangre , Enfermedades del Desarrollo Óseo/etiología , Enfermedades del Desarrollo Óseo/patología , Remodelación Ósea/efectos de los fármacos , Colágeno Tipo I/sangre , Módulo de Elasticidad/efectos de los fármacos , Fémur/efectos de los fármacos , Fémur/patología , Trastornos del Crecimiento/sangre , Trastornos del Crecimiento/etiología , Trastornos del Crecimiento/patología , Masculino , Desnutrición/tratamiento farmacológico , Minerales/sangre , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Tamaño de los Órganos/efectos de los fármacos , Hormona Paratiroidea/sangre , Péptidos/sangre , Propranolol/farmacología , Proteínas/análisis , Distribución Aleatoria , Ratas , Ratas Wistar , Soporte de Peso
3.
J S Afr Vet Assoc ; 60(1): 36-41, 1989 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2724286

RESUMEN

Plasma calcium, phosphorus and magnesium concentrations were determined in ewes and their single and twin lambs from birth for 120 days in Merino, Dohne Merino and South African Mutton Merino sheep. Mineral concentrations as well as the plasma calcium: phosphorus ratio were compared between breeds. Throughout the experimental period, plasma calcium and phosphorus concentrations were higher in both single and twin lambs than in the ewes of all 3 breeds. No breed differences in plasma calcium concentrations were found. Animals of the S.A. Mutton Merino breed had significantly higher (P less than 0.05) plasma phosphorus concentrations than the other 2 breeds. The plasma Ca:P ratio in the Merino and Dohne Merino ram lambs was approximately 1.1:1 and in the S.A. Mutton Merino 0.9:1. This converse plasma Ca:P ratio found in both the S.A. Mutton Merino ewes and lambs is believed to result in an induced plasma ionised calcium deficiency which leads to improper calcification of bone. This is believed to be a contributing factor in the bent-leg syndrome. No difference was recorded in body mass between ram lambs suffering from the bent-leg syndrome and unaffected ram lambs. Plasma magnesium concentrations were not affected by breed or age of the animals.


Asunto(s)
Enfermedades del Desarrollo Óseo/veterinaria , Calcio/sangre , Magnesio/sangre , Fósforo/sangre , Enfermedades de las Ovejas/sangre , Animales , Enfermedades del Desarrollo Óseo/sangre , Femenino , Pierna , Masculino , Ovinos , Síndrome/veterinaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA